menu search

RHHBY / Roche open to big acquisitions 'if it makes scientific and financial sense' - CEO tells newspaper

Roche open to big acquisitions 'if it makes scientific and financial sense' - CEO tells newspaper
Roche is open to making big acquisitions if they make "sense", Chief Executive Thomas Schinecker said, with the Swiss drugmaker unencumbered by its $20.7 billion deal last year to buy back its shares from Novartis. Read More
Posted: Sep 9 2023, 15:50
Author Name: Reuters
Views: 110168

RHHBY News  

Roche Agrees $7.1 Billion for Drug Company

By Barrons
October 23, 2023

Roche Agrees $7.1 Billion for Drug Company

It will buy immunology company Telavant Holdings from Roivant Sciences and Pfizer. more_horizontal

Roche splashes US$7.1 billion on new irritable bowel drug

By Proactive Investors
October 23, 2023

Roche splashes US$7.1 billion on new irritable bowel drug

Roche has agreed to pay US$7.1 billion for an early-stage inflammatory bowel disease treatment developed by US rivals Roivant and Pfizer. For its mon more_horizontal

Swiss pharma giant Roche agrees $7.1 billion deal to buy Telavant Holdings

By CNBC
October 23, 2023

Swiss pharma giant Roche agrees $7.1 billion deal to buy Telavant Holdings

Swiss health care company Roche announced it would acquire Telavant Holdings Monday, in a deal worth $7.1 billion. more_horizontal

Roche buys Telavant Holdings for $7.1 billion

By Reuters
October 23, 2023

Roche buys Telavant Holdings for $7.1 billion

Roche on Monday said it will buy Telavant, a developer of a new treatment for inflamatory bowel diseases, for an initial $7.1 billion from American bi more_horizontal

India is a ‘slow trundling elephant' but a viable alternative to China, says veteran investor David Roche

By CNBC
October 22, 2023

India is a ‘slow trundling elephant' but a viable alternative to China, says veteran investor David Roche

Veteran Investor David Roche said India has been aligning itself with the "democratic alliances" of the "richest and most vibrant economies" in the wo more_horizontal

Roche (RHHBY) Nine Months' Sales Fall on Lower COVID-19 Test Sale

By Zacks Investment Research
October 19, 2023

Roche (RHHBY) Nine Months' Sales Fall on Lower COVID-19 Test Sale

Roche (RHHBY) reports a sales decline in the first nine months of 2023 as COVID-19-test sales continue to dent its top line. Currency rate fluctuation more_horizontal

Roche's 9M sales down 6% on currency headwinds, drop in COVID sales

By Reuters
October 19, 2023

Roche's 9M sales down 6% on currency headwinds, drop in COVID sales

Roche said nine-month sales slipped 6% to 44.1 billion Swiss francs ($49.1 billion), hit by a sharp decline in sales of COVID-19 products and as a str more_horizontal

Roche's (RHHBY) MS Drug Reduces Brain Lesions in Phase II Study

By Zacks Investment Research
October 16, 2023

Roche's (RHHBY) MS Drug Reduces Brain Lesions in Phase II Study

Roche (RHHBY) presents new data from a phase II study, which shows that fenebrutinib is brain penetrant and reduces brain lesions in people with relap more_horizontal


Search within

Pages Search Results: